Tag: Phillip Morris

Information Gaps Hindering Uptake Of Smoke Free Tobacco Alternatives Among Adult Smokers

Michael Gwarisa

THE 7th Edition of the Tobacco Atlas, identified devastating health and economic costs of global tobacco use with indications that In 2019 alone, tobacco use caused more than 8.67 million deaths worldwide (6.53 million men, 2.14 million women) and approximately US $2 trillion in economic damage. Most deaths were attributable to smoking, but 1.3 million died from second hand smoke exposure. By Michael Gwarisa Another worrying trend the tobacco atlas picked was the growing use and smoking of tobacco by the youths. Youth tobacco use (girls and/or boys) increased in…

Read More

Phillip Morris & Swedish Match Amongst Leading Tobacco Companies Advancing Tobacco Harm Reduction- Tobacco Transformation Index Finds

Michael Gwarisa

THE first Tobacco Transformation Index released this week and made possible with funding from the Foundation for a Smoke-Free World, finds that most of the 15 largest tobacco companies are not making substantive progress in phasing out cigarettes and other high-risk tobacco products and transitioning smokers to reduced-risk alternatives. By Michael Gwarisa A small group of companies have made public commitments to harm reduction and backed them with significant investments. A majority of companies have made no such commitment to tobacco harm reduction. With 1.3 billion tobacco users in the…

Read More

FDA Authorizes Marketing of IQOS Tobacco Heating System with ‘Reduced Exposure’ Information

Michael Gwarisa

THE U.S. Food and Drug Administration authorized the marketing of Philip Morris Products S.A.’s “IQOS Tobacco Heating System” as modified risk tobacco products (MRTPs). By Michael Gwarisa This marks the second set of products ever to be authorized as MRTPs and the first tobacco products to receive “exposure modification” orders, which permits the marketing of a product as containing a reduced level of or presenting a reduced exposure to a substance or as being free of a substance when the issuance of the order is expected to benefit the health…

Read More